Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CFTR | P13569 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | PRKCI | P41743 | 2/20 | 0.54 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29412876 | 1.00 | NAPRT (0.61) | NAPRTALDH1A1CFTRHSD17B10TDP1 | |
| Hydrochloric Acid SCHEMBL29373852 | 0.98 | NAPRT (0.59) | NAPRTALDH1A1CFTRHSD17B10TDP1 | |
| SCHEMBL30753027 | 0.88 | NAPRT (0.56) | NAPRTALDH1A1CFTRHSD17B10TDP1 | |
| SCHEMBL219458 | 0.85 | NAPRT (0.66) | NAPRTALDH1A1TDP1PRKCIKDM4E | |
| SCHEMBL27958777 | 0.83 | NAPRT (0.63) | NAPRTALDH1A1TDP1PRKCIKDM4E | |
| SCHEMBL812065 | 0.81 | KDM4E (0.59) | ALDH1A1CFTRHSD17B10TDP1MAP2K1 | |
| SCHEMBL29923922 | 0.81 | NAPRT (0.56) | NAPRTALDH1A1HSD17B10TDP1PRKCI | |
| SCHEMBL1292847 | 0.81 | NAPRT (0.56) | NAPRTALDH1A1HSD17B10TDP1PRKCI | |
| SCHEMBL12517053 | 0.81 | NAPRT (0.56) | NAPRTALDH1A1PRKCIKDM4EPOLB | |
| SCHEMBL181049 | 0.81 | ALDH1A1 (0.60) | NAPRTALDH1A1HSD17B10KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113649055-B | Catalyst for selective hydrogenation of methyl picolinate and preparation method and application thereof | 湖北大学 | 2023-03-24 | — | — | CN | claimed |
| CN-113649055-A | Catalyst for selective hydrogenation of methyl picolinate and preparation method and application thereof | 湖北大学 | 2021-11-16 | — | — | CN | claimed |
| CN-101701031-A | Polypeptide condensing agent and synthesis method thereof | CHANGZHOU NANJING UNIVERSITY H | 2010-05-05 | — | — | CN | claimed |
| CN-122071467-A | Imidazo nitrogen heteroaryl oxazoline compound and preparation method and application thereof | 贵州大学 | 2026-05-22 | — | — | CN | disclosed |
| US-12630528-B2 | Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof | LG CHEM, LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| CN-115835909-B | Cannabinoid receptor type 2 (CB 2) modulators and uses thereof | 泰昂治疗公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-121673283-A | Pyridopyrimidinone derivative and preparation method and application thereof | 江苏海洋大学 | 2026-03-17 | — | — | CN | disclosed |
| EP-4665339-A1 | INHIBITING ALPHA V BETA 8 INTEGRIN | Morphic Therapeutic, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| US-12492207-B2 | Compounds, pharmaceutical formulations, and methods for treatment of cancer | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE OF NEW YORK (US) | 2025-12-09 | — | — | US | disclosed |
| US-20250326746-A1 | EIF4E INHIBITORS AND USES THEREOF | PIC Therapeutics, Inc. | 2025-10-23 | — | — | US | disclosed |
| US-12421243-B2 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms | PRINTNET KERESKEDELMI ÉS SZOLGÁLTATÓ KFT. (HU) | 2025-09-23 | — | — | US | disclosed |
| US-4128551-A | HERBICIDE | THE DOW CHEMICAL CO. (US) | 1978-12-05 | — | — | US | disclosed |
| US-4098792-A | HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
| US-4085279-A | HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1978-04-18 | — | — | US | disclosed |
| US-4085278-A | HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1978-04-18 | — | — | US | disclosed |
| US-4082758-A | HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1978-04-04 | — | — | US | disclosed |
| US-4082759-A | HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1978-04-04 | — | — | US | disclosed |
| US-4058533-A | HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1977-11-15 | — | — | US | disclosed |
| US-4014888-A | HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1977-03-29 | — | — | US | disclosed |
| US-3989507-A | HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492207-B2 | Compounds, pharmaceutical formulations, and methods for treatment of cancer | GAK, CCNK, CDK1 | NAPRT 2822/4885ALDH1A1 4510/4885CFTR 4828/4885 |
| US-20250326746-A1 | EIF4E INHIBITORS AND USES THEREOF | EIF4E, EIF4EBP1, EIF4A1 | NAPRT 2953/4885ALDH1A1 4776/4885CFTR 4043/4885 |
| US-12421243-B2 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms | MYH2, MYLK2, MYO1B | NAPRT 3389/4885ALDH1A1 2854/4885CFTR 1525/4885 |
| US-12630528-B2 | Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof | DGAT2, DGAT1, SOAT2 | NAPRT 1108/4885ALDH1A1 597/4885CFTR 2553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.